Genentech and Roche Sign Deal for GlycArt’s Anticancer Antibody Therapy
By Helen Scrutton
Pharma Deals Review: Vol 2008 Issue 101 (Table of Contents)
Published: 3 Oct-2008
DOI: 10.3833/pdr.v2008.i101.118 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
Genentech and Roche have entered into a new deal this month, although not the anticipated acquisition of the biotech by the Swiss giant...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS